CBIO Earnings CRESCENT BIOPHARMA, INC.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| FY 2024 | 2024-12-31 | -0.59 | 2025-02-13 | 10-K |
| Q3 2024 | 2024-09-30 | -0.48 | 2024-11-13 | 10-Q |
| Q2 2024 | 2024-06-30 | -0.32 | 2024-08-08 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.04 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -0.58 | 2025-02-13 | 10-K |
| Q3 2024 | 2023-09-30 | -0.44 | 2024-11-13 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.30 | 2024-08-08 | 10-Q |
| Q1 2025 | 2023-03-31 | -0.17 | 2025-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -0.89 | 2024-03-27 | 10-K |
| Q3 2023 | 2022-09-30 | -0.70 | 2023-11-03 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.53 | 2023-08-02 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.28 | 2023-05-03 | 10-Q |
| FY 2023 | 2021-12-31 | -1.23 | 2024-03-27 | 10-K |
| Q3 2022 | 2021-09-30 | -0.90 | 2022-11-09 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.56 | 2022-08-03 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.28 | 2022-04-28 | 10-Q |
| FY 2022 | 2020-12-31 | -1.12 | 2023-03-29 | 10-K |
| FY 2021 | 2019-12-31 | -1.34 | 2022-03-03 | 10-K |
| Q2 2016 | 2016-06-30 | -0.80 | 2016-08-04 | 10-Q |
| FY 2016 | 2015-12-31 | -0.47 | 2017-03-01 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.